Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Pediatrics and Neonatology
  • Pediatrics and Neonatology News
  • Pfizer Covid-19...

Pfizer Covid-19 Vaccine safe and effective in Adolescents: NEJM study

dr anushaWritten by dr anusha Published On 2021-05-31T13:25:07+05:30  |  Updated On 2021-06-02T14:38:35+05:30
Pfizer Covid-19 Vaccine safe and effective in Adolescents: NEJM study

Adolescents play an important role in SARS-CoV-2 transmission, thus their vaccination may prevent disease and contribute to herd immunity. Researchers from California observed favorable safety and efficacy of BNT162b2 Covid-19 vaccine in 12-16 year old adolescents.BNT162b2 (Pfizer-BioNtech) is a Covid-19 vaccine containing nucleoside-modifies mRNA encoding SARS-CoV2 spike glycoprotein....

Adolescents play an important role in SARS-CoV-2 transmission, thus their vaccination may prevent disease and contribute to herd immunity. Researchers from California observed favorable safety and efficacy of BNT162b2 Covid-19 vaccine in 12-16 year old adolescents.

BNT162b2 (Pfizer-BioNtech) is a Covid-19 vaccine containing nucleoside-modifies mRNA encoding SARS-CoV2 spike glycoprotein. This vaccine was approved in Dec 2020 for adults after phase 3 trials globally since the vaccine had favorable safety profile. The COVID-19 pandemic had interrupted education and social development of students and simultaneously burdening the caregivers, hence safe, efficacious vaccines for younger populations are paramount.

Dr.Robert et al in collaboration with Pfizer and BioNtech conducted a randomized trial in healthy individuals aged 12 years and above to assess safety, efficacy and immunogenicity of this vaccine. In the study 2264 participants in the age 12-15 years(cohort 1) and 3788 participants between age 16-25 years of age(cohort 2) were randomized into two subsets in each cohort- one subset who received the vaccine and other subset who received placebo. Persons with previous clinical or virological Covid-19 infection were excluded.

Major findings of the study include:

1. In both age cohorts , injection site pain was the most common local reaction. Severe injection site pain was reported in 1.5% of 12-15 year old participants and in 3.4% of 16-25 year old participants.

2. Headache and fatigue were the most frequently reported systemic events among both age cohorts. In general systemic side-effects were reported more often after BNT162b2 dose 2 than after dose 1.

3. Upon analysis greater immunogenicity to vaccine was observed in adolescents than in young adults as indicated by serum-neutralising geometric mean titer one month after BNT162b2 dose 2 which was 1283.0 in 12-15 year-old cohort and was 730.8 in the 16-25 year-old cohort.

4. Among 1983 participants in the 12-15 years old cohort who could be evaluated for efficacy , no cases of Covid-19 with an onset of 7 or more days after dose 2 was observed; which correspond to observed vaccine efficacy of 100%.

The favourable safety profile from this study is important because a precedent exists for vaccines being more reactogenic when administered to younger people.

Although children generally have a lower burden of symptomatic Covid-19 than adults; schools,youth sports, and other community gatherings may represent important sources of ongoing outbreaks and transmission, despite high rates of adult immunization. Hence, vaccination of adolescents will allow them to reintegrate into society and resume in-person learning safely, which are especially important outcomes given the severe mental health effects of the Covid-19 pandemic on this group.

Authors conclude-"The BNT162b2 vaccine in 12-to-15-year-old recipients had a favorable safety profile, produced a greater immune response than in young adults, and was highly effective against Covid-19".

Source:NEJM

covid-19 vaccine bnt162b2 SARS COV2 adolescent vaccination New England Journal of Medicine 
Source : New England Journal of Medicine
dr anusha
dr anusha

    MBBS, M.D. Pediatrics

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok